FDA Seizes Tissue Valve Firm’s Entire Product Line, Citing Sterilization Issues
This article was originally published in The Gray Sheet
Executive Summary
U.S. marshals confiscated all devices manufactured by New Jersey-based Shelhigh in an April 17 seizure resulting from FDA concerns with product sterility